1
|
Maqsood S, Din FU, Khan SU, Elahi E, Ali Z, Jamshaid H, Zeb A, Nadeem T, Ahmad W, Khan S, Choi HG. Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects. Life Sci 2022; 311:121198. [DOI: 10.1016/j.lfs.2022.121198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 11/03/2022] [Accepted: 11/11/2022] [Indexed: 11/17/2022]
|
2
|
Yuan X, Meng D, Cao P, Sun L, Pang Y, Li Y, Wang X, Luo Z, Zhang L, Liu G. Identification of pathogenic genes and transcription factors in vitiligo. Dermatol Ther 2019; 32:e13025. [PMID: 31306558 DOI: 10.1111/dth.13025] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Revised: 07/01/2019] [Accepted: 07/11/2019] [Indexed: 12/21/2022]
Abstract
Our study aimed to identify the key genes and upstream regulators in vitiligo. To screen the pathogenic genes of vitiligo, an integrated analysis was performed by using the microarray datasets in vitiligo derived from the Gene Expression Omnibus (GEO) database. The functional annotation and potential pathways of differentially expressed genes (DEGs) were further explored by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. We constructed a vitiligo-specific transcriptional regulatory network to identify crucial transcriptional factors that target the DEGs in vitiligo. From two GEO datasets, we identified 1863 DEGs (744 downregulated DEGs and 1,119 upregulated DEGs [false discovery rate < 0.05, |Combined.ES| > 1]) between lesional tissues and nonlesional tissues. GO and KEGG analyses revealed that ubiquitin-mediated proteolysis and the endoplasmic reticulum were significantly enriched pathways for DEGs. The expressions of premelanosome (PMEL), melan-A (MLANA), dopachrome tautomerase (DCT), SRY-boxtranscription factor 10 (SOX10), tyrosinase-related protein 1 (TYRP1), and melanocortin 1 receptor (MC1R) were shown to be involved in the pathogenesis of vitiligo. We concluded that PMEL, MLANA), DCT, SOX10, TYRP1, and MC1R may play a role in vitiligo, among which TYRP1 and MC1R are regulated by forkhead box J2 (FOXJ2). Our finding may contribute to the development of new potential biomarkers, reveal the underlying pathogenesis of vitiligo, and identify novel therapeutic targets for vitiligo.
Collapse
Affiliation(s)
- Xiangfeng Yuan
- Department of Dermatology, Shandong University, Jinan, Shandong, China.,Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Dan Meng
- Weifang Medical University, Weifang, Shandong, China
| | - Peihua Cao
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Lina Sun
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Yunyan Pang
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Yuan Li
- Department of Dermatology, Binzhou Medical University Hospital, Binzhou, Shandong, China
| | - Xing Wang
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Zengxiang Luo
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| | - Li Zhang
- Department of Dermatology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, China
| | - Guoyan Liu
- Department of Dermatology, Weifang Medical University Hospital, Weifang, Shandong, China
| |
Collapse
|
3
|
Kasemeier-Kulesa JC, Romine MH, Morrison JA, Bailey CM, Welch DR, Kulesa PM. NGF reprograms metastatic melanoma to a bipotent glial-melanocyte neural crest-like precursor. Biol Open 2018; 7:bio.030817. [PMID: 29175861 PMCID: PMC5829509 DOI: 10.1242/bio.030817] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Melanoma pathogenesis from normal neural crest-derived melanocytes is often fatal due to aggressive cell invasion throughout the body. The identification of signals that reprogram de-differentiated, metastatic melanoma cells to a less aggressive and stable phenotype would provide a novel strategy to limit disease progression. In this study, we identify and test the function of developmental signals within the chick embryonic neural crest microenvironment to reprogram and sustain the transition of human metastatic melanoma to a neural crest cell-like phenotype. Results reveal that co-culture of the highly aggressive and metastatic human melanoma cell line C8161 upregulate a marker of melanosome formation (Mart-1) in the presence of embryonic day 3.5 chick trunk dorsal root ganglia. We identify nerve growth factor (NGF) as the signal within this tissue driving Mart-1 re-expression and show that NGF receptors trkA and p75 cooperate to induce Mart-1 re-expression. Furthermore, Mart-1 expressing C8161 cells acquire a gene signature of poorly aggressive C81-61 cells. These data suggest that targeting NGF signaling may yield a novel strategy to reprogram metastatic melanoma toward a benign cell type. Summary: We identify and test the function of nerve growth factor to reprogram human metastatic melanoma cells to a less aggressive phenotype. This article has an associated First Person interview with the first author of the paper as part of the supplementary information.
Collapse
Affiliation(s)
| | - Morgan H Romine
- Duke University, Margolis Center for Health Policy, Washington, DC 20004, USA
| | - Jason A Morrison
- Stowers Institute for Medical Research, Kansas City, MO 64110, USA
| | - Caleb M Bailey
- Department of Biology, Brigham Young University-Idaho, Rexburg, ID 83460, USA
| | - Danny R Welch
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Paul M Kulesa
- Stowers Institute for Medical Research, Kansas City, MO 64110, USA .,Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| |
Collapse
|